Cerner Corp

Most Recent

  • uploads///SP  index
    Company & Industry Overviews

    S&P 500 Index Nears Record High amid Earnings Season

    The S&P 500 Index, represented by the SPDR S&P 500 ETF (SPY), rose 0.3% on October 23, nearing the all-time high it saw in July.

    By Maitali Ramkumar
  • uploads///healthcare spending in
    Company & Industry Overviews

    Will Amazon’s PillPack Purchase Boost Its Healthcare Expansion?

    Amazon recently announced that it was purchasing PillPack, an online pharmacy that primarily serves customers who take multiple medications.

    By Sophia Nicholson
  • uploads///microscope _
    Company & Industry Overviews

    IQVIA Has Fallen 2.9%, but Analysts Are Still on Board

    On May 16, IQVIA Holdings’ (IQV) closing price was $99.3, almost 2.9% lower than its closing price on May 15.

    By Margaret Patrick
  • uploads///Graph
    Company & Industry Overviews

    The Hospital Business Remains 1of HAE’s Key Growth Drivers

    In fiscal 3Q18, Haemonetics (HAE) reported revenue of close to $46.7 million in its hospital business, a YoY (year-over-year) rise of ~9.1%.

    By Margaret Patrick
  • uploads///MASI
    Company & Industry Overviews

    Masimo’s Geographic Segments in Fiscal 2017

    In fiscal 2017, Masimo generated an operating cash flow of $56 million—compared to $419.1 million in fiscal 2016.

    By Kenneth Smith
  • uploads///microscope _
    Company & Industry Overviews

    Masimo and Its Peers: Analysts’ Ratings in March 2018

    Of the five analysts covering Masimo in March 2018, two analysts gave the stock a “strong buy” rating, while three analysts gave it a “hold” rating.

    By Kenneth Smith
  • uploads///ambulance __
    Company & Industry Overviews

    Analyst Ratings for BioTelemetry and Its Peers in March 2018

    Of the seven analysts covering BioTelemetry in March 2018, two have given it a “strong buy” rating, and five have given it a “buy.”

    By Kenneth Smith
  • uploads///BEAT
    Company & Industry Overviews

    Understanding BioTelemetry’s Business Strategy

    BioTelemetry’s (BEAT) business strategy is to solidify its position as a leading provider of outpatient cardiac monitoring services.

    By Kenneth Smith
  • uploads///dispensing business model change
    Company & Industry Overviews

    BD Advances Medication Management Business through Innovations

    Becton, Dickinson and Company (BDX), or BD, established itself as the leader in the medication management market with the acquisition of CareFusion in 2015.

    By Sarah Collins
  • uploads///Amazon AWS segment revenues and op proits
    Company & Industry Overviews

    Why Amazon Wants to Partner with EHR Developer Cerner

    According to CNBC, Amazon (AMZN) could be on the verge of making a deal with healthcare information technology company Cerner (CERN).

    By Sophia Nicholson
  • uploads///long term stock performance
    Company & Industry Overviews

    BD Stock Fell 2.7% on September 13: Should Investors Worry?

    Becton, Dickinson and Company (BDX) closed at $196.62 on September 13, 2017.

    By Sarah Collins
  • uploads///carefusion acquisition
    Company & Industry Overviews

    Becton Dickinson’s CareFusion Synergies and Integration Progress

    Becton Dickinson (BDX) expects the CareFusion deal to result in cost synergies of $325.0 million to $350.0 million by 2018.

    By Sarah Collins
  • uploads///dispensing business model change
    Company & Industry Overviews

    Headwind for Becton Dickinson: US Dispensing Business

    Becton Dickinson (BDX) is the leading player in the US dispensing business. Its Pyxis system sales contribute significantly to the company’s total revenues.

    By Sarah Collins
  • uploads///part
    Real Insights

    U.S. Moat Index: Analyzing Its Performance in April

    TransDigm Group (TDG) rose 12% in April. Two other additions, Cerner and Guidewire Software, added to the U.S. Moat Index’s performance in April.

    By VanEck
  • uploads///dispensing business model change
    Company & Industry Overviews

    Understanding BD’s Business Model Changes in Dispensing

    BD has accelerated its plans to shift from a product-centric to customer-centric end-to-end solutions provider through various collaborations and partnerships.

    By Sarah Collins
  • uploads///Part  Graph
    Company & Industry Overviews

    Chinese Trade Numbers Fall for 16th Straight Time: Effect on XLV

    Chinese exports fell 25.4% on a year-over-year basis, and imports fell 13.8%, marking the 16th straight monthly decline. XLV fell 1.2% yesterday in response to the news.

    By Peter Neil
  • uploads///Graph Part
    Company & Industry Overviews

    Biotechnology Traded below Moving Averages in Last Week of August

    Biotechnology and pharmaceuticals are the two largest subgroups of XLV. In the biotechnology subgroup, 100% of the stocks are trading below their 20-day, 50-day, and 100-day moving averages.

    By Peter Neil
  • uploads///allscripts
    Fund Managers

    Blue Harbour Ups its Stakes in Allscripts Healthcare Solutions

    Blue Harbour raised its stakes in Allscripts Healthcare Solutions (MDRX) in 4Q14. The company accounts for 5.91% of the fund’s portfolio in 4Q14.

    By Patricia Garner
  • uploads///MDRX
    Consumer

    Eminence Capital ups position in Allscripts Healthcare Solutions

    Allscripts provides clinical, financial, and population health management solutions to physicians, health systems, hospitals, and post-acute organizations.

    By Samantha Nielson
  • Healthcare

    Computer Programs and Systems, Inc.’s superior value proposition

    Computer Programs and Systems, Inc. (CPSI): Moat CPSI has a superior product and value proposition evidenced by their market share, ROE, margins, and through CUSH’s independent channel checks. CPSI has taken more hospitals to Meaningful Use than its next five direct competitors combined. Implementation of the CPSI’s EHR system is typically one to two months […]

    By CUSH Capital
  • Healthcare

    Computer Programs and Systems, Inc.’s impressive management team

    Computer Programs and Systems, Inc. (CPSI): Management team At CUSH, we hold a monthly investors club for area executives and other successful investors. One of the members got us excited about the idea after speaking very highly of the CPSI, sharing great insight. This, coupled with having recently read an article from Forbes[1. Forbes, “Land Shares […]

    By CUSH Capital
  • Healthcare

    New hospital trends benefit Computer Programs and Systems, Inc.

    Computer Programs and Systems, Inc. (CPSI) investment thesis This section includes a description of the business and a quick summary of the key points to the investment thesis, including how the idea was originally brought to our attention. Computer Programs and Systems, Inc. (CPSI) is a healthcare information technology company that designs, develops, markets, installs […]

    By CUSH Capital
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.